Back to Search
Start Over
Kymera expands HS and AD Phase 2 trials following review
- Source :
- The Fly. July 8, 2024
- Publication Year :
- 2024
-
Abstract
- Kymera Therapeutics (KYMR) announced that following a review of preliminary KT-474 safety and efficacy data by an Independent Data Review Committee, Sanofi (SNY) has informed Kymera that it intends to [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.800510567